Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC).Prevention of chemotherapy and radiotherapy induced emesis: results of the Perugia Consensus Conference. Ann Oncol1998; 9: 811–819.
2.
The Italian Group for Antiemetic Research.Dexametha-sone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy. New Eng J Med2000; 342: 1554.
3.
The Italian Group for Antiemetic Research.Transferability to clinical practice of the results of controlled clinical trials: the case of antiemetic prophylactic treatment for cancer chemotherapy-induced nausea and vomiting. Ann Oncol1998; 9: 759–765.
4.
De AngelisV., RoilaF., PatoiaL.: Impact on antiemetic prescriptions of the consensus conference and of an expert's visit to oncological centers. Proc Am Soc Clin Oncol2000, A2386.
5.
NavariR.M., ReinhardtR.R., GrallaR.J.: Reduction of cisplatin-induced emesis by a selective neurokinin-1 receptor antagonist. New Eng J Med1999; 340: 190.
6.
GrilliR., ApoloneG., NicolucciA.: The impact of management guidelines on the care of breast, colorectal and ovarian cancer patients in Italy. Medical Care1991; 29(1): 50–63.
7.
CleelandC.S., GoninR., HatfieldA.K.: Pain and its treatment in outpatients with metastatic cancer. New Eng J Med330, 9: 1994.
8.
EsikO., SeitzW., LoveyJ.: External audit on the clinical practice and medical decision-making at the departments of radiotherapy in Budapest and Vienna. Ra-diother Oncol1999; 51(81): 87–94.
